vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and VALMONT INDUSTRIES INC (VMI). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× VALMONT INDUSTRIES INC). VALMONT INDUSTRIES INC runs the higher net margin — 10.5% vs -127.8%, a 138.3% gap on every dollar of revenue. On growth, VALMONT INDUSTRIES INC posted the faster year-over-year revenue change (6.2% vs -2.5%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -0.5%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Valmont Industries, Inc. is a large, publicly held American manufacturer of Valley center pivot and linear irrigation equipment, windmill support structures, lighting and traffic poles and steel utility poles.
PRGO vs VMI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.0B |
| Net Profit | $-1.4B | $108.0M |
| Gross Margin | 32.6% | 30.8% |
| Operating Margin | -116.0% | 15.1% |
| Net Margin | -127.8% | 10.5% |
| Revenue YoY | -2.5% | 6.2% |
| Net Profit YoY | -3093.9% | 23.8% |
| EPS (diluted) | $-10.23 | $5.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.1B | $1.0B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.0B | $969.3M | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $1.1B | $1.0B | ||
| Q2 24 | $1.1B | $1.0B |
| Q1 26 | — | $108.0M | ||
| Q4 25 | $-1.4B | $168.0M | ||
| Q3 25 | $7.5M | $99.0M | ||
| Q2 25 | $-8.4M | $-4.0M | ||
| Q1 25 | $-6.4M | $87.3M | ||
| Q4 24 | $-44.4M | $77.7M | ||
| Q3 24 | $-21.0M | $83.1M | ||
| Q2 24 | $-108.4M | $99.7M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | 32.6% | 29.8% | ||
| Q3 25 | 36.1% | 30.4% | ||
| Q2 25 | 34.4% | 30.6% | ||
| Q1 25 | 37.6% | 30.0% | ||
| Q4 24 | 33.9% | 30.2% | ||
| Q3 24 | 37.2% | 29.6% | ||
| Q2 24 | 37.0% | 30.8% |
| Q1 26 | — | 15.1% | ||
| Q4 25 | -116.0% | 11.2% | ||
| Q3 25 | 7.0% | 13.5% | ||
| Q2 25 | 4.3% | 2.8% | ||
| Q1 25 | 4.5% | 13.2% | ||
| Q4 24 | 10.0% | 11.6% | ||
| Q3 24 | 7.4% | 12.3% | ||
| Q2 24 | -2.5% | 14.2% |
| Q1 26 | — | 10.5% | ||
| Q4 25 | -127.8% | 16.2% | ||
| Q3 25 | 0.7% | 9.5% | ||
| Q2 25 | -0.8% | -0.4% | ||
| Q1 25 | -0.6% | 9.0% | ||
| Q4 24 | -3.9% | 7.5% | ||
| Q3 24 | -1.9% | 8.1% | ||
| Q2 24 | -10.2% | 9.6% |
| Q1 26 | — | $5.51 | ||
| Q4 25 | $-10.23 | $9.02 | ||
| Q3 25 | $0.05 | $4.98 | ||
| Q2 25 | $-0.06 | $-1.53 | ||
| Q1 25 | $-0.05 | $4.32 | ||
| Q4 24 | $-0.32 | $3.85 | ||
| Q3 24 | $-0.15 | $4.11 | ||
| Q2 24 | $-0.79 | $4.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $160.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $1.7B |
| Total Assets | $8.5B | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $160.2M | ||
| Q4 25 | — | $187.1M | ||
| Q3 25 | $432.1M | $226.1M | ||
| Q2 25 | $454.2M | $208.5M | ||
| Q1 25 | $409.9M | $184.4M | ||
| Q4 24 | $558.8M | $164.3M | ||
| Q3 24 | $1.5B | $200.5M | ||
| Q2 24 | $542.8M | $163.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $795.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $730.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $2.9B | $1.6B | ||
| Q3 25 | $4.4B | $1.6B | ||
| Q2 25 | $4.5B | $1.5B | ||
| Q1 25 | $4.4B | $1.6B | ||
| Q4 24 | $4.3B | $1.5B | ||
| Q3 24 | $4.6B | $1.5B | ||
| Q2 24 | $4.5B | $1.5B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $8.5B | $3.4B | ||
| Q3 25 | $10.1B | $3.4B | ||
| Q2 25 | $10.1B | $3.3B | ||
| Q1 25 | $9.8B | $3.4B | ||
| Q4 24 | $9.6B | $3.3B | ||
| Q3 24 | $11.2B | $3.5B | ||
| Q2 24 | $10.4B | $3.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | — |
| Free Cash FlowOCF − Capex | $148.6M | — |
| FCF MarginFCF / Revenue | 13.4% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $175.4M | $111.2M | ||
| Q3 25 | $51.7M | $112.5M | ||
| Q2 25 | $75.9M | $167.6M | ||
| Q1 25 | $-64.5M | $65.1M | ||
| Q4 24 | $312.6M | $193.4M | ||
| Q3 24 | $42.2M | $225.1M | ||
| Q2 24 | $9.5M | $130.8M |
| Q1 26 | — | — | ||
| Q4 25 | $148.6M | $70.4M | ||
| Q3 25 | $29.8M | $70.6M | ||
| Q2 25 | $56.7M | $135.6M | ||
| Q1 25 | $-90.0M | $34.8M | ||
| Q4 24 | $274.9M | $167.8M | ||
| Q3 24 | $15.1M | $204.6M | ||
| Q2 24 | $-18.9M | $112.5M |
| Q1 26 | — | — | ||
| Q4 25 | 13.4% | 6.8% | ||
| Q3 25 | 2.9% | 6.7% | ||
| Q2 25 | 5.4% | 12.9% | ||
| Q1 25 | -8.6% | 3.6% | ||
| Q4 24 | 24.2% | 16.2% | ||
| Q3 24 | 1.4% | 20.1% | ||
| Q2 24 | -1.8% | 10.8% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 3.9% | ||
| Q3 25 | 2.1% | 4.0% | ||
| Q2 25 | 1.8% | 3.0% | ||
| Q1 25 | 2.4% | 3.1% | ||
| Q4 24 | 3.3% | 2.5% | ||
| Q3 24 | 2.5% | 2.0% | ||
| Q2 24 | 2.7% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | 6.89× | 1.14× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 2.49× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | 1.31× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
VMI
| Infrastructure | $803.2M | 78% |
| Agriculture | $226.0M | 22% |
